成功用芬戈莫德治疗中枢神经系统移植物抗宿主病。
Successful treatment with fingolimod of graft-versus-host disease of the central nervous system.
机构信息
Allogeneic Stem Cell Transplantation Unit, Department of Hematology.
Department of Neurology, Salengro Hospital.
出版信息
Blood Adv. 2018 Jan 2;2(1):10-13. doi: 10.1182/bloodadvances.2017011478. eCollection 2018 Jan 9.
Abstract
Fingolimod could be efficient to treat GVHD of the central nervous system.Further research should explore the use of fingolimod and other sphingosine-1-phosphate receptor agonists to prevent or treat GVHD.
摘要
芬戈莫德可能对治疗中枢神经系统移植物抗宿主病有效。应进一步研究芬戈莫德和其他鞘氨醇-1-磷酸受体激动剂在预防或治疗移植物抗宿主病中的作用。
相似文献
1
Successful treatment with fingolimod of graft-versus-host disease of the central nervous system.成功用芬戈莫德治疗中枢神经系统移植物抗宿主病。
Blood Adv. 2018 Jan 2;2(1):10-13. doi: 10.1182/bloodadvances.2017011478. eCollection 2018 Jan 9.
2
Central nervous system graft-versus-host disease (CNS-GvHD) after allogeneic haematopoietic stem cell transplantation.异基因造血干细胞移植后的中枢神经系统移植物抗宿主病（CNS-GvHD）
BMJ Case Rep. 2018 Jan 12;2018:bcr-2017-221840. doi: 10.1136/bcr-2017-221840.
3
4
Graft-versus-host disease can be separated from graft-versus-lymphoma effects by control of lymphocyte trafficking with FTY720.通过使用FTY720控制淋巴细胞运输，可将移植物抗宿主病与移植物抗淋巴瘤效应区分开来。
J Clin Invest. 2003 Mar;111(5):659-69. doi: 10.1172/JCI16950.
5
Successful treatment of meningeal graft-versus-host disease in a haematopoietic stem cell transplant recipient.造血干细胞移植受者脑膜移植物抗宿主病的成功治疗。
Int J Hematol. 2015 Feb;101(2):203-6. doi: 10.1007/s12185-014-1704-x. Epub 2014 Nov 22.
6
Sphingosine-1-Phosphate Receptor Agonist Fingolimod Increases Myocardial Salvage and Decreases Adverse Postinfarction Left Ventricular Remodeling in a Porcine Model of Ischemia/Reperfusion.鞘氨醇-1-磷酸受体激动剂 fingolimod 增加缺血/再灌注猪模型的心肌挽救并减少不良的梗死后左心室重构。
Circulation. 2016 Mar 8;133(10):954-66. doi: 10.1161/CIRCULATIONAHA.115.012427. Epub 2016 Jan 29.
7
Superior GVHD-free, relapse-free survival for G-BM to G-PBSC grafts is associated with higher MDSCs content in allografting for patients with acute leukemia.对于急性白血病患者，GVHD 无复发生存率优于 G-BM 到 G-PBSC 移植物，这与同种异体移植中更高的髓系抑制细胞含量有关。
J Hematol Oncol. 2017 Jul 4;10(1):135. doi: 10.1186/s13045-017-0503-2.
8
TAK1 inhibition ameliorates survival from graft-versus-host disease in an allogeneic murine marrow transplantation model.在同种异体小鼠骨髓移植模型中，TAK1抑制作用可改善移植物抗宿主病的存活率。
Int J Hematol. 2018 Feb;107(2):222-229. doi: 10.1007/s12185-017-2345-7. Epub 2017 Oct 12.
9
Cannabidiol for the Prevention of Graft-versus-Host-Disease after Allogeneic Hematopoietic Cell Transplantation: Results of a Phase II Study.大麻二酚预防异基因造血细胞移植后移植物抗宿主病：一项II期研究的结果
Biol Blood Marrow Transplant. 2015 Oct;21(10):1770-5. doi: 10.1016/j.bbmt.2015.05.018. Epub 2015 May 30.
10
Successful treatment with steroids of upper gastrointestinal acute graft vs. host disease after hematopoietic stem cell transplantation.造血干细胞移植后上消化道急性移植物抗宿主病的类固醇成功治疗。
Endoscopy. 2001 Nov;33(11):985-7. doi: 10.1055/s-2001-17922.
引用本文的文献
1
Graft-Versus-Host Disease Mouse Models: A Clinical-Translational Perspective.移植物抗宿主病小鼠模型：临床转化视角
Methods Mol Biol. 2025;2907:1-56. doi: 10.1007/978-1-0716-4430-0_1.
2
CNS manifestations in acute and chronic graft-versus-host disease.急性和慢性移植物抗宿主病中的中枢神经系统表现
Brain. 2025 Apr 3;148(4):1122-1133. doi: 10.1093/brain/awae340.
3
The functional antagonist of sphingosine-1-phosphate, FTY720, impairs gut barrier function.鞘氨醇-1-磷酸的功能性拮抗剂FTY720会损害肠道屏障功能。
Front Pharmacol. 2024 Aug 19;15:1407228. doi: 10.3389/fphar.2024.1407228. eCollection 2024.
4
Complex interactions of cellular players in chronic Graft-versus-Host Disease.慢性移植物抗宿主病中细胞成分的复杂相互作用。
Front Immunol. 2023 Jun 26;14:1199422. doi: 10.3389/fimmu.2023.1199422. eCollection 2023.
5
Possible Chronic Graft-versus-host Disease in the Central Nervous System Manifesting as Cerebellar Ataxia after Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia.异基因造血干细胞移植治疗急性髓系白血病后发生以小脑性共济失调为表现的可能中枢神经系统慢性移植物抗宿主病
Intern Med. 2023 Mar 1;62(5):779-786. doi: 10.2169/internalmedicine.9720-22. Epub 2022 Aug 10.
6
Retention of Donor T Cells in Lymphohematopoietic Tissue and Augmentation of Tissue PD-L1 Protection for Prevention of GVHD While Preserving GVL Activity.在保留移植物抗肿瘤活性的同时，保留供者 T 细胞于淋巴造血组织并增强组织 PD-L1 保护，以预防移植物抗宿主病。
Front Immunol. 2022 May 23;13:907673. doi: 10.3389/fimmu.2022.907673. eCollection 2022.
7
A Case Report of Central Nervous System Graft-Versus-Host Disease and Literature Review.中枢神经系统移植物抗宿主病一例报告及文献复习
Front Neurol. 2021 Mar 10;12:621392. doi: 10.3389/fneur.2021.621392. eCollection 2021.
8
Monogenic Immune Diseases Provide Insights Into the Mechanisms and Treatment of Chronic Graft-Versus-Host Disease.单基因免疫性疾病为慢性移植物抗宿主病的发病机制和治疗提供了新视角。
Front Immunol. 2021 Feb 4;11:574569. doi: 10.3389/fimmu.2020.574569. eCollection 2020.
9
Current Preventions and Treatments of aGVHD: From Pharmacological Prophylaxis to Innovative Therapies.急性移植物抗宿主病的当前预防与治疗：从药物预防到创新疗法
Front Immunol. 2020 Dec 17;11:607030. doi: 10.3389/fimmu.2020.607030. eCollection 2020.
本文引用的文献
1
Compositional changes of B and T cell subtypes during fingolimod treatment in multiple sclerosis patients: a 12-month follow-up study.多发性硬化症患者接受芬戈莫德治疗期间B细胞和T细胞亚群的组成变化：一项为期12个月的随访研究。
PLoS One. 2014 Oct 31;9(10):e111115. doi: 10.1371/journal.pone.0111115. eCollection 2014.
2
The S1P1 receptor-selective agonist CYM-5442 reduces the severity of acute GVHD by inhibiting macrophage recruitment.鞘氨醇-1-磷酸受体1（S1P1）选择性激动剂CYM-5442通过抑制巨噬细胞募集来减轻急性移植物抗宿主病（GVHD）的严重程度。
Cell Mol Immunol. 2015 Nov;12(6):681-91. doi: 10.1038/cmi.2014.59. Epub 2014 Aug 4.
3
FTY720 impairs CD8 T-cell function independently of the sphingosine-1-phosphate pathway.FTY720 可独立于鞘氨醇-1-磷酸途径损害 CD8 T 细胞功能。
J Neuroimmunol. 2014 May 15;270(1-2):13-21. doi: 10.1016/j.jneuroim.2014.03.007. Epub 2014 Mar 11.
4
FTY720 ameliorates murine sclerodermatous chronic graft-versus-host disease by promoting expansion of splenic regulatory cells and inhibiting immune cell infiltration into skin.FTY720通过促进脾脏调节性细胞的扩增并抑制免疫细胞浸润皮肤来改善小鼠硬皮病样慢性移植物抗宿主病。
Arthritis Rheum. 2013 Jun;65(6):1624-35. doi: 10.1002/art.37933.
5
Central and peripheral nervous system immune mediated demyelinating disease after allogeneic hemopoietic stem cell transplantation for hematologic disease.血液病异基因造血干细胞移植后中枢及外周免疫介导的脱髓鞘疾病。
J Neurooncol. 2012 Nov;110(2):251-6. doi: 10.1007/s11060-012-0962-9. Epub 2012 Aug 23.
6
Clinical immunology of the sphingosine 1-phosphate receptor modulator fingolimod (FTY720) in multiple sclerosis.多发性硬化症中鞘氨醇 1-磷酸受体调节剂 fingolimod（FTY720）的临床免疫学。
Neurology. 2011 Feb 22;76(8 Suppl 3):S20-7. doi: 10.1212/WNL.0b013e31820db341.
7
FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation.FTY720（芬戈莫德）在多发性硬化症动物模型中的疗效需要星形胶质细胞鞘氨醇 1-磷酸受体 1（S1P1）的调节。
Proc Natl Acad Sci U S A. 2011 Jan 11;108(2):751-6. doi: 10.1073/pnas.1014154108. Epub 2010 Dec 21.
8
Graft-versus-host disease of the CNS after allogeneic bone marrow transplantation.异基因骨髓移植后中枢神经系统的移植物抗宿主病
J Clin Oncol. 2009 Oct 20;27(30):e147-9. doi: 10.1200/JCO.2009.21.7919. Epub 2009 Aug 10.
9
Insights into the mechanism of FTY720 and compatibility with regulatory T cells for the inhibition of graft-versus-host disease (GVHD).FTY720抑制移植物抗宿主病（GVHD）的机制及与调节性T细胞的兼容性研究
Blood. 2007 Nov 1;110(9):3480-8. doi: 10.1182/blood-2007-05-087940. Epub 2007 Jul 2.
10
Regulation of donor T cells in the tolerant rats to graft-versus-host disease by FTY720 following small bowel transplantation.小肠移植后FTY720对耐受大鼠供体T细胞移植物抗宿主病的调控作用
Transplant Proc. 2006 Dec;38(10):3181-3. doi: 10.1016/j.transproceed.2006.10.091.
Zotero 插件